Team

Founder and CEO

Rene is a life science professional with more than 25 years of pharmaceutical commercial and development experience in GSK, Organon, Novartis and Takeda

 
Former Vice President of Global Franchises in Neuroscience and CVM at Takeda
>7 years of leadership experience in Digital Therapeutics, at both Novartis and Takeda, where he developed Digital Therapeutic concepts in NeuroPsychiatric disorders.

Rene holds a B.Sc in Information Management from the University of Applied Sciences Larenstein
Executive training certification in Finance from the Harvard Business School

Chief Medical Officer

Roger qualified in medicine 1981 and has worked in surgery, medicine and A&E until training in psychiatry 1987-1990.
Specialized in geriatric psychiatry.
NHS consultant 1993-2013
Set up Kingshill Research Centre in 1994 developing it in to a national and international facility. 

UK coordinating investigator on many occasions. Published over 100 peer reviewed papers, several books and chapters
8 years as clinical tutor and 4 years as Academic Secretary of the Royal College of Psychiatrists Faculty of Old age Psychiatry. Invited speaker at many national and international conferences

Worked 11 years in senior NHS management - last six as Clinical director of Older Peoples services.

Successfully responsible for a 55m budget and clinical governance of 800 staff

Chief Science Officer

Dr. Boustani is a geriatrician, a neuroscientist, and an implementation scientist with extensive experience in designing, evaluating, implementing, and scaling healthcare innovations with a focus on brain health. 

Dr Boustani is a Professsor of Medicine and Adjunct Professor in Bioinformatics at the School of Informatics and Computing at  Indiana University

Malaz is the Director of Senior Care Innovation at Eskenazi Health Care, the Richard M Fairbanks Professor of Aging Research

Founding Chief Innovation and Implementation Officer for Indiana University Center for Health Innovation and Implementation 

Dr. Boustani has built a clinical laboratory of more than 2,000 ambulatory practices serving at least 10 million lives within five Midwestern States (Illinois, Indiana, Michigan, Ohio, and Kentucky) 

Lead the execution of numerous clinical research studies funded by the National Institutes of Health, the Agency for Healthcare Research and Quality, and the Centers for Medicare and Medicaid Services.

He has more than 180 peer-reviewed publications and just published two books about Agile Implementation and Agile Network. 

Chief Technologist

Ivan has experience with building commercial software for more than 20 years.
Experience with being technical leader in multiple enterprise level and startup companies, where he was in charge of leading system design, implementation, and optimization.

Led the design and implementation of multiple SaaS, IoT, and industrial systems for startups and enterprise companies.

He's been passionate about programming ever since he got his first PC (Pentium II) and he feels fortunate that his favorite hobby turned out to be his profession.
Besides the software design and implementation, Ivan has a significant experience in people, project, and product management.

Ivan has an MSc in Computer Science from the Faculty of Technical Sciences from the University of Novi Sad and is a post-graduate pursuing his PhD.

Chief Commercial Officer

Twenty-year veteran with extensive proven go-to-market success selling novel and disruptive robotic and SaaS technologies across the globe

Matt brings deep expertise in building and leading high performing businesses and world-class global commercial organizations with deep leadership experience and success in domestic and international market access and brand building

Prior to joining OptiChroniX, Matt was the Chief Commercial Officer of 91.life that built and led the global commercial organization and the go-to-market strategy which included forming strategic alliances with Yale New Haven Health System, LSU, and ETH Zurich in just his first 90 days.

Prior to moving into the digital therapeutics space Matthew drove the earliest clinical and geographical adoptions of robotic surgery throughout North America for companies such as Intuitive Surgical, Hansen Medical, and most recently Stereotaxis

Matt has been recognized as an industry expert and key partner in driving patient flow patterns leading to exponential growth and expansion of health systems on the leading edge of technology throughout North America

Mr. Werner received his BA in Economics from Wesleyan University

COO and Finance

Anna has significant experience in controlling, strategy & risk management with major global fast moving consumer good companies.

She is the  Head of Basel Section and Board member of the Swiss Hospital Service of the Order of Malta, 

Suffering herself from rheumatoid arthritis in her youth, Anna gives a unique perspective as a patient who embraces digitalization of healthcare as a chance to improve patient outcomes and lives. 

Anna holds an M.Sc. (cum laude) International Management/CEMS from Rotterdam School of Management and executive education at IMD Lausanne and IESE Business School. 

Anna is an alumna of Evonik’s RISE talent program and a One Young World Ambassador

Chief Regulatory and Compliance Officer

Albrecht is a transformational leader with an international career of more than 20 years at the interface of science, policy and regulation in fast-paced Biotech and FMCG environments of significant growth

Extensive experience in national and supranational regulation of consumer products and non-food products
Albrecht has conducted, directed, commissioned and published scientific and clinical research, and forged first-in-class partnerships with NGO and strategic collaboration with government-owned research organisations advancing evidence-informed approaches to public health policy and practice. 

Ph.D. in Natural Sciences from the University of Göttingen, MBA from Anaheim University Akio Morita School of Business, postgraduate certificates from Oxford and Hull.

General Counsel and CIPO

Mark has 27 years of global legal experience
Former Vice President and  General Counsel of Butamax®Advanced Biofuels LLC (Joint Venture between BP and DuPont)

He was General Counsel and Compliance Officer of Ilera Healthcare, a successful startup 

Corporate Intellectual Property Litigation Counsel for DuPont strategic businesses - 13 years

Extensive technology, licensing and commercial transaction experience

Registered U.S. Patent Attorney - United States Patent and Trademark OfficeIntellectual Property consultant for startups and emerging companies
B.A. Chemistry - Kenyon College